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Abstract 
Background: The purpose of this study was to assess the antitumoral effect of the methanol extract (MeOH) from 
Nitraria retusa leaves and to investigate its immunomodulatory activity that mediated the prevention of tumor pro‑
gression in tumor‑bearing mice.
Methods: Balb/c mice weighing 18–20 g were subcutaneously implanted with B16‑F10 cells then injected intra‑
peritoneally, 7 days later with (200 mg/kg bw) of MeOH extract, for 21 days. After euthanization on day 21, the tumors 
were weighed. Lymphocyte proliferation, cytotoxic T lymphocyte (CTL) and NK activity were evaluated using the MTT 
assay. Macrophage phagocytosis was studied by measuring their lysosomal activity and nitric oxide production.
Results: The methanol extract inhibited significantly the growth of the implanted tumor, and increased remarkably 
splenocyte proliferation as well as NK and CTL activities, in tumor‑bearing mice. It also promoted lysosomal activity of 
treated animal macrophages.
Conclusion: Our findings suggest that antitumoral effect of MeOH extract is related with to immunomodulatory 
activity.
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Résumé 
Introduction: Le but de cette étude est d’évaluer l’effet antitumoral de l’extrait méthanolique (MeOH) issue des 
feuilles de N. retusa via son potentiel immunomodulateur et sa capacité à prévenir la progression tumoral chez des 
souris porteuses de tumeurs.
Méthodes: Pour cette étude, nous avons implanté par voie sous‑cutanée, chez des souris Balb/c de 18 à 20 g, des 
cellules B16‑F10. Après apparition de la tumeur, au bout de 7jours de l’injection de B16‑F10, nous avons entamé un 
traitement par injection intrapéritonéale de 200 mg/kg de poids corporel, d’extrait MeOH, et ce durant 21 jours. Les 
animaux sont euthanasiés au 21ème jour, et les tumeurs sont pesées. La prolifération des splénocytes et des  
lymphocytes T cytotoxiques (CTL) à été évalué à l’aide du test au MTT. L’évaluation de l’activité NK à également été 
effectuée à l’aide du par le même test. Dans un second volet, nous avons étudié l’activité phagocytaire des  
macrophages en évaluant leur activité lysosomale et la production d’oxyde nitrique.
Résultats: L’extrait MeOH révèle, un fort potentiel inhibiteur de la croissance de la tumeur transplantée, une  
augmentation de façon remarquable de la prolifération des splénocytes ainsi qu’une forte induction des activités  
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Background
Melanoma is the most aggressive form of skin cancer 
with an annual incidence consistently increasing world-
wide [1]. Treatment options are limited for advanced 
stage patients and new therapies showing success in only 
a subset of patients [2].
The immune system is capable of recognizing mela-
noma tumors, and patients readily develop melanoma-
specific T cell responses [3]. However, in most cases, 
these immune responses ultimately fail to eradicate 
established melanoma tumors [4].
Immunomodulation through natural or synthetic sub-
stances may be considered an alternative for the preven-
tion and cure of neoplastic diseases [5]. The enhancement 
of host immune response has been recognized as a possi-
ble means of inhibiting tumor growth without harming the 
host [6]. Therefore, it is very important to investigate novel 
antitumor substances with improving immunity potential.
Nitraria retusa is commonly used in Tunisian tra-
ditional medicine to treat stomach pain, ulcers and 
gastritis. However, there are no studies regarding the 
antitumoral or immunomodulatory activities of N. 
retusa. Recently, we have demonstrated that methanol 
extract from N. retusa leaves exhibited antiproliferative 
potential against cancer cell lines in vitro [7]. Moreover, 
apoptotic effect of this plant has been carried out in some 
cancerous cell lines [7, 8]. However, there are no studies 
regarding the antitumoral or immunomodulatory activi-
ties of this plant.
Thus, we evaluated in this study the melanoma growth 
inhibiting capacity, of the MeOH extract against B16-F10 
mouse melanoma cells, implanted in Balb/c mice in vivo. 
In addition, we investigated the potency of the tested 
extract on host immune responses of tumor-bearing 
mice.
This study show, for the first time, that methanolic 
extract of N. retusa leaves exert in vivo antitumoral and 
immunomodulatory activities.
Results
Phytochemical study of methanol extract from N. retusa 
leaves
As described in our previous study [7], methanol 
(MeOH) extract exhibited the highest quantities of fla-
vonoids and polyphenols respectively (146.52  μg/ml 
concentration equivalent quercetin and 30  μg/ml con-
centration equivalent gallic acid).
Cytotoxic effect on B16‑F10 cell line
We have examined the effect of different concentrations 
(ranging from 10 to 1000 μg/ml) of (MeOH) extract on 
B16-F10 cell growth using the MTT assay. The results of 
this assay are reported in (Fig.  1). MeOH extract inhib-
ited the malignant tested cell growth.
NK et CTL chez des souris porteuses de tumeurs. Aussi l’extrait a considérablement induit l’activité phagocytaire des 
macrophages en augmentant leur activité lysosomale ainsi que la production de monoxide d’azote, par ces cellules.
Conclusion: Nos résultats suggèrent fortement que l’effet antitumoral de l’extrait méthanolique passe par son 
potentiel immunomodulatrice.
Fig. 1 Anti‑proliferative effect of methanol extract of Nitraria retusa leaf on B16‑F10 melanoma cells. Values represent the mean ± SD of three 
separate experiments
Page 3 of 9Boubaker et al. Cancer Cell Int  (2015) 15:82 
Acute toxicity
No mortality was recorded in the group of animals 
treated with the MeOH extract at 200 mg/kg BW.
Effect of methanol extract on weight and volume of tumor
Our results suggest that (MeOH) extract significantly 
suppresses growth of tumor cells in the tumor-bearing 
mice. The average tumor size in (MeOH) extract-treated 
group was significantly smaller than that in the positive 
control group (Fig.  2). The inhibition of tumor volume 
reached 95.19  %. Consistent with this result, the aver-
age tumor weight after the administration to animals of 
the extract, was significantly lower than in positive con-
trol (animal with tumor) (PC). The inhibition percentage 
reached 88.95 % (Fig. 3).
Effect of methanol extract on splenocytes proliferation
The results showed that spontaneous proliferative capac-
ity of splenic lymphocytes decreased in positive control 
mice (PC) compared to healthy mice (NC). Proliferative 
capacities decreased, after tumor induction, to 22.94  %. 
Treatment with methanol extract (200 mg/kg b.w) signifi-
cantly restored the proliferation of splenic lymphocytes. 
The percentage of stimulation reached 64.2 % (Fig. 4).
Effect of methanol extract on NK cell activity
The results of this assay were reported in Fig. 5. In fact, 
NK activity increases from 21.89  % in healthy mice to 
48.66 % in the tumor-bearing (PC) mice. Treatment with 
(MeOH) extract increased the NK activity by 136.27 % in 
tumor-injected mice, revealing thus an induction of this 
cell defense system.
Effect of methanol extract on CTL activity
Spleen cells from the experimental mice were assessed for 
specific cytotoxic activity against B16F10 melanoma cells 
(Fig. 6). Data reported in Fig. 5 showed that the presence 
of the tumor, significantly suppressed cytotoxic capaci-
ties of CTL. The CTL activity decreased from 27.33 % in 
the group of healthy mice (NC) to 13.77 % in the tumor-
bearing mice group (PC). Treatment with MeOH extract 
allows rising of CTL activity, in the tumor-injected mice, 
to 54.64 % on days 21.
Effect of methanol extract on peritoneal macrophage 
lysosomal activity
The activity in macrophages harvested from tumor-
injected mice (PC) decreased significantly (by 65.87  %) 
when compared to untreated animals.Whereas lysosomal 
activity of macrophages obtained from MeOH extract 
treated tumor bearing mice (200 mg/kg b.w) increased by 
255.37 % when compared to that of untreated mice cells 
(Fig. 7).
Effect of methanol extract on peritoneal macrophage nitric 
oxide production
Macrophages isolated from mice treated with MeOH 
extract (200  mg/kg b.w) for 24  h, display a significant 
increase in NO production. In fact, NO concentration 
rises from 14.38  µM (PC: positive control) to 23.35  µM 
(macrophage treated mice) Fig. 8
Discussion
The number of new cancer cases each year is projected 
to rise worldwide by about 70  % by 2030 due to demo-
graphic changes alone, with the largest increases in the 
lower-income countries. Lung, liver, colorectal and breast 
cancers are the most commonly diagnosed in males and 
females respectively, and these cancers also represent the 
most frequent types of cancer related deaths. Thus, medi-
cal advances in disease treatment are an issue at a later 
stage and should be made available globally [9].
Our study revealed that MeOH extract inhibits mela-
noma cell proliferation in a dose dependent manner. This 
cytotoxicity may be ascribed to the presence of specific 
components such as polyphenols and flavonoids [7], 
as far as. They were the main constituents of the tested 
extract. In addition, Martinez et al. and Yanes et al. [10, 
11] reported previously then antiproliferative activity 
of such compounds against melanoma cells. Our aim 
was to investigate alternative phytotherapy solutions to 
current anticancer treatments and preventing cancer 
Fig. 2 Inhibitory effect of N. retusa methanol extract on subcuta‑
neous melanoma in Balb/c mice. Mice were sacrificed and then 
analyzed for representative macroscopic photographs of melanoma 
tumor weight and volume were determined. a Animal bearing tumor 
(positive control) (PC), b from animals bearing tumor and treated 
with MeOH extract at 200 mg/kg b.w
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development. Thus we demonstrated that N. retusa leaf 
extract  exhibits an anti-tumoral potency in melanoma-
bearing mice. Despite the fact that the mechanisms 
underlying MeOH extract anti-tumor potency may be 
complex, our data showed that this potency was most 
likely related to the regulation of the immune responses. 
Host immunity is involved in the development and pro-
gression of malignant disease. Some studies had reported 
that anti-tumor potencies of plant extracts should involve 
the enhancement of the main executors of the immune 
defense cells, such as lymphocytes and macrophages 
[12]. Thus, T cells can assign tumor cells directly or can 
act indirectly by releasing cytokines that amplify cyto-
toxic T lymphocyte responses or activate NK cells and 
macrophages [13]. In fact, CTL and NK cells are rich in 
cytoplasmic granules. Following degranulation, the cells 
produce specific biologically active substances, which 
have a cytotoxic activity on target cells. These gran-
ules contain perforin, granzymes, granulysin and other 
Fig. 3 Effect of methanol extract from N. retusa on B16F10 melanoma growth in Balb/C mice. A Effect of tested extract on tumor weight, B effect of 
tested extract on tumor volume. All data shown are mean (±SD) percent inhibition values, and are representative of two independent experiments. 





























Fig. 4 Effect of methanol extract from N. retusa on splenocytes prolif‑
eration in vivo. All values shown are mean (±SD) % activities relative 
to those of cells from PBS‑only mice (non‑tumor‑injected; TN) at each 
time point, and representative of two independent experiments 
(n = 10 mice per group/time point). **P < 0.01 Significantly different 
from that of the control mice (NC). (c) p < 0.001 significantly different 
from that of mice with melanoma (PC)
Fig. 5 Effect of methanol extract from N. retusa on NK cell activity 
in vivo. All data shown are mean (±SD)  % NK activity, and are repre‑
sentative of two independent experiments (n = 10 mice per group/
time point). *P < 0.05 significantly different from that of the control 
mice (NC). (a) P < 0.05 significantly different from that of mice with 
melanoma (PC)
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effector molecules involved in the anti-tumor potency, as 
well as some unidentified components [14, 15].
Our study revealed that treatment of tumor-bearing 
mice with MeOH extract increases their NK cells activity 
of. In fact, NK cell are known to be the major mediators 
of the innate anti-tumor immune responses; they eradi-
cate tumors by recognizing stress-inducible ligands on 
tumors cells and execute tumor cells with perforin and 
granzyme in vivo [16]. NK cells stamp out solid tumors 
by apoptosis [16].
The proliferation of splenocytes induced by MeOH 
extract in tumor bearing mice could be attributed to fla-
vonoids and polyphenols [17], a class of agents already 
known to be mechanistically active on immune system 
[18] and to modulate the immune activity [19].
One of the most important non-specific immune 
activities in  situ, is phagocytosis performed by mac-
rophages (as well as by other types of leukocytes). 
Phagocytosis is accompanied by the release of lyso-
somal enzymes like acid phosphatase (AP) used for 
the killing and digesting of microbial pathogens. The 
higher AP activity, the greater the phagocytic stimula-
tion and intracellular killing capacity [20]. Our study 
showed that the tested extract increases significantly 
cellular lysosomal enzyme activity. This is most likely 
attributed to the flavonoid, tannin and polyphenol 
contents of the tested extract, which could be respon-
sible for this particular immunomodulatory potency 
[18].
Macrophage phagocytosis is also assigned by the liber-
ation of free radicals such as nitric oxide (NO), involved 
in pathogen killing [21]. We showed that MeOH extract 
induces NO synthesis, by peritoneal macrophages, 
reflecting phagocytic stimulation; as such, the extract 
could act as an immunostimulant of innate immunity. 
Many plants have been shown to affect lysosomal activ-
ity and NO synthase activity in macrophages [22, 23]. 
This result could be ascribed to the presence of poly-
phenols and flavonoids in methanol extract. Polyphe-
nols are known to enhance the nitroblue tetrazolium 
(NBT) reducing activity of macrophages [24], to activate 
morphological change (spreading) of peritoneal mac-
rophages, and to induce various antitumor cytokines 
including tumor necrosis factor (TNF), interleukin 
(IL)-1 [25], and nitric oxide [26].
It is noteworthy that development of melanoma is 
associated with immune suppression [27]. This is in 
Fig. 6 Effect of methanol extract from N. retusa on cytotoxic 
T‑lymphocyte (CTL) activity in vivo. All data shown are mean (±SD) % 
killing activity, and are representative of two independent experi‑
ments (n = 10 mice per group/time point). *P < 0.05 significantly 
different from that of the control mice (NC). (b) P < 0.01 significantly 




























Fig. 7 Effect of methanol extract from N. retusa on lysosomal activity 
of mouse peritoneal macrophages in vivo. All values shown are mean 
(±SD) % activities relative to those of cells from PBS‑only mice (non‑
tumor‑injected; TN) at each time point, and representative of two 
independent experiments (n = 10 mice per group/time point). (b) 
P < 0.01 significantly different from that of mice with melanoma (PC)
Fig. 8 Effect of the methanol extract from N. retusa on production of 
the nitrite by mouse peritoneal macrophages in vivo. Data shown are 
mean (±SD) percentage of NO production from three independent 
experiments. *P < 0.05 significantly different from that of the control 
mice (NC). (c) P < 0.001 significantly different from that of mice with 
melanoma (PC)
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accordance with our findings, which demonstrate a 
decrease in CTL activity in mice bearing-tumor but not 
those treated with the tested extract.
On the other hand, we observed a significant pro-
apoptotic activity of the methanol extract against several 
as tumoral cell lines in  vitro K562 [7], TK6 and B16f10 
(data not shown), we assessed the ability of the extract to 
inhibit cell proliferation in vivo. This study showed that 
200 mg/kg bw of MeOH extract reduced tumor size and 
weight. Such results were in agreement with findings of 
other researchers who reported the in vivo anti-tumoral 
activity of some plant extracts [12].
Conclusion
Our results indicate for the first time, a significant anti-
tumor effect of N. retusa leaf extract. This property 
is associated to immunomodulating effect upon sple-
nocytes, NK cells and macrophages. However further 
characterization of bioactive compounds in the crude 
extract is warranted in future studies. The pharmaco-
logically active ingredients and the signaling pathways 




Leaves of N. retusa were collected from saline soils in 
Sahline, a region situated in mid-Tunisia, in December 
2006. Their identification was done by Pr. M. Cheieb 
(Department of Botany, Faculty of Sciences, University 
of Sfax, Tunisia), according to the Flora of Tunisia [28, 
29]. A voucher specimen (N.r-12.06) has been kept in 
our laboratory for future reference. The leaves were hade 
dried, powdered, and stored in a tightly closed container 
for further use.
Preparation of methanolic extract
Three hundred and fifty grams of powder, from dried 
leaves, were sequentially extracted in a Soxhlet appara-
tus (6  h) (AM Glassware, Aberdeen, Scotland, United 
Kingdom) with hexane, chloroform, ethyl acetate and 
methanol solvents. We obtained the correspondent 
extracts for each solvent. Hexane (Hex), chloroform 
(Chl) and methanol (MeOH) extracts, with different 
polarities, were concentrated to dryness and the resi-
dues were kept at 4  °C. Then, each extract was resus-
pended in dimethyl sulfoxide solvent (DMSO). Plant 
materials were screened for the presence of tannins, 
flavonoids, coumarins and sterols using the methods 
previously described by Boubaker, et al. [30]. Amongst 
these extracts, only the methanolic one was used in the 
evaluation of the in vivo antitumoral and immumodu-
latory effects.
Cell line and culture
The B16F10 melanoma line was obtained from Ameri-
can Type Culture Collection (ATCC, Manassas, VA, 
USA) and grown at 37 °C in a humidified incubator with 
5 % CO2 at 37 °C. The cells were cultured in RPMI-1640 
medium supplemented with 10  % (v/v) fetal calf serum 
(FCS, Biowhitaker, Lonza, Belgium), 2  mM glutamine, 
1  % NEA (100X), 1  % sodium pyruvate 100  mM (com-
plete RPMI).
Assay for cytotoxic activity
Cytotoxicity of N. retusa extracts against B16F10 cells 
was estimated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyltetrazolium bromide (MTT) assay, based on the 
reduction of the MTT by mitochondrial dehydroge-
nases in viable cells. The resulting blue formazan prod-
uct is measured spectrophotometrically [31] Cells were 
seeded in a 96-well plate at a concentration of 5 ×  103 
cells/well and incubated at 37  °C for 24 h in a 5 % CO2 
enriched atmosphere. The extract was firstly dissolved in 
1 % DMSO, then in the cell growth medium. Cells were 
incubated again at 37 °C for 48 h with each of the tested 
extract at concentrations ranging from 10 to 1000  μg/
ml. Next, the medium was removed and cells in each well 
were incubated with 50  μl of MTT solution (5  mg/ml) 
at 37  °C for 4 h. MTT solution was then discarded and 
50 μl of 100 % DMSO were added to dissolve the insolu-
ble formazan crystal. The optical density was measured at 
540 nm. Each drug concentration was tested in triplicate.
The cytotoxic effects of the extract was estimated 
in terms of cell population growth inhibition percent-
age and expressed as IC50 which is the concentration of 
extract that reduces the absorbance of the treated cells 
by 50 % with reference to the control (cells treated with 
DMSO). The IC50 value was graphically obtained from 
the dose–response curves.
Experimental animals
Specific pathogen-free Balb/c mice (6–8 week-old males, 
20–25 g) were obtained from the Pasteur Institute (Tunis, 
Tunisia). The animals were housed in polypropylene cages 
with stainless steel grill tops and provided with bedding 
of clean paddy husk. The animals were acclimatized to 
laboratory conditions for one week prior to treatment. All 
mice were housed under standard conditions of tempera-
ture (25  °C), humidity (60 %), and light (12-h light/dark) 
in an accredited pathogen-free facility. The mice were fed 
with standard laboratory pelleted feed. All animal experi-
ments were performed in accordance with the guidelines 
for the care and use of laboratory animals published by 
the US National Institutes of Health. The study protocol 
was approved by the Ethics Committee of the University 
Hospital Fattouma-Bourguiba of Monastir, Tunisia.
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Subcutaneous melanoma model in vivo treatment
Mice were separated into three experimental groups 
(n = 60; two separate studies using n = 10/group): mice 
in the first group were treated with intraperitoneal injec-
tion of MeOH at 200  mg/kg BW starting immediately 
after seven days of a single subcutaneous (SC) injection 
of 2 × 106 viable B16F10 tumor cells into their right hind 
leg (thigh) on Day 0. The second group was comprised 
of B16F10-injected mice that were treated only with 
PBS (PC: positive control) throughout the post-injection 
period. The last group (NC: negative control)—‘healthy 
mice’—received no tumor cells but received injections 
of PBS only in the post-injection period. The process-
ing time of treatment period was for 21  days and every 
2 days.
On Day 21, all mice were weighed and sacrificed. 
Solid tumors were collected and weighed, the long-
est and shortest diameters of tumors were meas-
ured with a vernier caliper and the tumor volume was 
determined according to established procedure [32]: 
Tumor volume (mm3)  =  (L  ×  W2)  ×  0.5 and then the 
inhibitory rate against tumor growth was calculated as 
(%) =  [(PC −  Trt)/PC] ×  100  %, where PC is the aver-
age tumor weight in the tumor control mice (“PC” group 
above) and Trt is the weight in mice that had received 
methanolic extract.
Acute toxicity
For acute toxicity, mice were divided into two groups 
of six animals each. The first group served as a control 
and received only the vehicle solution, while the second 
group was treated by intraperitoneal injection (i.p) with 
dose of 200 mg/kg b.w. of MeOH extract.
Splenocytes proliferation assay
Mice were killed on day 21, and the spleen of each mouse 
was isolated aseptically and minced using a sterile for-
ceps. The splenocytes were then centrifuged (1500 rpm, 
10  min) and any red blood cells present lysed by re-
suspending the pellet in lysing buffer (144  mM NH4Cl, 
1.7  mM Tris-Base) and placing on ice for 10  min. Cells 
were then washed twice with PBS and then re-suspended 
in complete RPMI. Splenocytes proliferation assays were 
performed by using the MTT method. Splenocytes sus-
pensions in complete RPMI (5  ×  105 cells/well) were 
incubated in 96-well plates for 48 h at 37 °C. Thereafter, 
the plates were centrifuged at 1500 rpm for 10 min, then 
each cell pellet was resuspended in 50 µl MTT (5 mg/ml) 
in RPMI. The plate was then incubated a further 2  h at 
37 °C before the plates were centrifuged again, the MTT 
solution in each well was removed, and 100  µl DMSO 
were added to each well. Percentage proliferation was 
calculated as:
 [33].
Cytotoxic activity of natural killer (NK) cells
Splenocytes isolated from each mouse were incubated 
with K562 cells. Briefly, splenocytes (5  ×  106 cells/
well) (effector cell) were seeded in the well with the 
K562 cells (5 × 104 cells/well) (targeted cell). The plates 
were incubated at 37 °C with 5 % CO2 for 4 h, and 50 µl 
MTT solution (5  mg/ml) were added to each well. The 
plate were incubated a further 2 h and subjected to the 
protocols outlined above to assess formazan forma-
tion. NK cell activity was calculated as: NK activity 
(%) = 100 × (ODT − (ODS − ODE))/ODT) where ODT, 
optical density value of target cells control, ODS, optical 
density value of test sample, ODE, optical density value 
of effector cells control [34]
Assay of cytotoxic T‑lymphocyte (CTL) activity
Briefly, B16-F10 cells and isolated splenocytes were used 
as target and effector cells, respectively. The assay was 
performed as outlined above for the NK assay except that 
cells were incubated for 24 h. 50 µl MTT solution (5 mg/
ml) were added to each well and the plate was incubated 
a further 2  h and subjected to the protocols outlined 
above to assess formazan formation. The percentage of 
target cells killed was determined as in the NK assay:
where ODT, optical density value of target cells control, 
ODS, optical density value of test sample, ODE, optical 
density value of effector cells control.
Cellular lysosomal enzyme activity
Peritoneal macrophages were obtained after intraperi-
toneal injection of 5  ml sterile PBS, and withdrawal of 
the fluid. Obtained cells were washed twice by PBS and 
re-suspended in complete RPMI 1640; cell viability was 
assessed via trypan blue exclusion. One hundred µl of 
the macrophage cell suspension (6 ×  106 cells/ml) were 
seeded in 96 flat-botton well plates treated with differ-
ent concentrations of extract and incubated for 24  h at 
37  °C, under a humid atmosphere and at 5  % CO2. The 
adherent cells are taken up in 20 µl Triton X-100 (1 %), 
10 µl of p-nitrophenyl phosphate (p-NPP) (100 mM), the 
acid phosphatase substrate, and 50  µl of citrate buffer 
(0.1  M, pH  =  5). The whole is incubated at 37  °C in a 
humid atmosphere and 5 % CO2 for 30 min before 150 µl 
of borate buffer (pH 9.8, 0.2 M) was added to each well, 
and the absorbance measured at 405 nm. The percentage 
Proliferation (%)
= 100 × (OD sample−OD NC)/OD NC)
CTL activity (%)
= 100 × (ODT− (ODS − ODE))/ODT,
Page 8 of 9Boubaker et al. Cancer Cell Int  (2015) 15:82 
of the activity is determined by the following formula: 
Activity (%) = 100 × (OD sample-OD control)/OD con-
trol [35].
Nitric oxide production
The amount of NO released by macrophages was meas-
ured by determining the amounts of accumulated nitrite 
(NO2) in cell free supernatants via the Griess reaction 
[36]. In brief, isolated macrophages of each group were 
incubated for 24 h. Nitrite was then measured by adding 
100 µl Griess reagent (1 % sulfanilamide and 0.1 % naph-
thylenediamine in 5 % phosphoric acid) to 100 µl of har-
vested culture supernatant. The optical density at 570 nm 
(OD570) was then measured in a microplate reader 
(Thermo Scientific, Vantaa, Finland). NO concentrations 
were calculated by comparison with the OD570 of a stand-
ard solution of sodium nitrite diluted in culture medium 
and placed in parallel wells in the assay plates.
Statistical analysis
Data were collected and expressed as the mean ± stand-
ard deviation of three independent experiments and ana-
lyzed for statistical significance from control. The data 
were tested for statistical differences by one-way ANOVA 
followed by student test using statistica. The criterion for 
significance was set at P < 0.05.
Abbreviations
MeOH: methanol; DMSO: dimethyl sulfoxide; NK: natural killer; CTL: cytotoxic 
T‑lymphocyte; NO: nitric oxide.
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